Advertisement
Advertisement

ADTX

ADTX logo

Aditxt, Inc. Common Stock

0.12
USD
Sponsored
0.00
+1.89%
May 08, 15:58 UTC -4
Closed
exchange

After-Market

0.10

-0.02
-17.51%

Aditxt, Inc. Common Stock Profile

About

Aditx Therapeutics Inc. is a life sciences company. It engages in developing biotechnologies specifically focused on health of the immune system through immune monitoring and reprogramming. Aditx Therapeutics Inc. is based in LOMA LINDA, CA.

Info & Links

CEO

Amro Albanna

Headquarters

2569 WYANDOTTE STREET, SUITE 101
MOUNTAIN VIEW, CA 94043, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.aditxt.com

Auditor

dbbmckennon

Share holders

174

Employees

26

Aditxt, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

88.64K

Enterprise Value

-1.25M

Enterprise Value/EBITDA(ttm)

0.07

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

14.14

Price to Book(mrq)

0.01

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

-534.09%

Operating Margin(ttm)

-624905.06%

Profit Margin(ttm)

-41154.57%

Return on Equity(ttm)

-374.60%

Return on Invested Capital(ttm)

-334.43%

Return on Assets(ttm)

-92.82%

Income Statement

Revenue(ttm)

3.10K

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

300.00

EBITDA(ttm)3

-17.81M

Net Income Available to Common(ttm)

-43.10M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

1.74

52-Week Change

-99.99%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

904.47K

Dividend Yield

0.00%

Float4

91.00K

% Held by Insiders

0.01%

% Held by Institutions

15.54%

Balance Sheet

Total Cash(mrq)

3.20M

Total Cash Per Share(mrq)

3.54

Total Debt(mrq)

1.86M

Total Debt/Equity(mrq)

-55.14%

Current Ratio(mrq)

0.02%

Quick Ratio(mrq)

0.31%

Book Value Per Share(mrq)

-1.39K

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.00K

Free Cash Flow(ytd)

-16.44M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement